Mazor Robotics received three purchase orders for its Renaissance robot-assisted systems.
Here are three things to know:
1. The company received a purchase order for two Renaissance systems from its distribution partner in China — Cicel Science & Technology. These are the first systems sold into the Chinese market after receiving China Food and Drug Administration approval.
2. Mazor Robotics also received a purchase order for one Renaissance system from its distribution partner in Taiwan. The system is the third in total to be distributed in Taiwan and is expected to be installed at a newly opened spine hospital.
3. Mazor sold five Renaissance systems in the third quarter of 2014. System kit sales, service and other revenue sources increased to $2.5 million in the third quarter, a 67 percent increase over the same period last year.
More articles on devices:
6 points on FDA panel physicians …and their payments from device companies
What is Stryker responsible for in the OtisMed settlement? 5 things to know
What happens when data links device company payments with physician decisions?